Siastatin B (1), a neuraminidase inhibitor isolated from a Streptomyces culture,1} was totally synthesized from L-ribose and the absolute configuration was related with that of sialic acid (A^-acetylneuraminic acid, 2) by us ( Fig. 1) .2)3) In our studies on siastatin B analogues, some optically active compounds were synthesized, and (2jR, 3i^,4i?, 55)-2-acetamido-3 ,4, 5-trihydroxy-5-(nitromethyl)piperidine and its enantiomer inhibiting a-glucosidase and (27?,3i?,4i?,5i?)-2-acetamido-3,4,5-trihydroxypiperidine-5-carboxylic acid inhibiting /?-glucuronidase were obtained.4) In this paper, we describe the total syntheses of analogues of 1, namely, (2i?, 3JR, 4i?, 55 )-2-(trifluoroacetamido)-3,4,5-trihydroxypiperidines and their enantiomers having nitromethyl (3 and 4), aminomethyl (5 and 6) and carboxyl (7 and 8) groups at C-5, and (2JR,3 i?,4i?,5i?)-5-(aminomethyl)-3 ,4,5-trihydroxy-2-(hydroxyacetamido)piperidine (9). Synthesis In the course of our study4) of the relationship between structure and biological activity, wewere interested in the conversion of the functional group at the C-2 position, affecting the function of the imino group of the piperidine ring. The imino group probably interacts with the glycopyranosyl binding site to inhibit the enzymatic process. Thus, compounds (3~8) were effectively prepared from ( + )-(2jR,3,R,4jR,5*S)-A^-(^rr-butoxycarbonyl)-5-O-(^r^-butyldimethylsilyl)-3,4,5-trihydroxy-3 ,4-O-isopropylidene-2-phthal- f A part of this paper was presented at the 2nd International Symposiumon the Chemical Synthesis of Antibiotics and the Related Microbial Products, Abstracts, 1-25, p. 68, Oiso, Japan, 1990. imidopiperidine (10) and its antipode (ll) by similar reaction sequences to that used for the synthesis of 1. 2) Treatment of 10 with hydrazine and subsequent treatment with ethyl trifluoroacetate and diisopropylethylamine in Af,Af-dimethylformamide (DMF) gave the trifluoroacetamide 12 in 92% yield. Removal of the ter^-butyldimethylsilyl group with tetrabutylammonium fluoride and oxidation of the resulting hydroxyl group of 13 with ruthenium tetroxide produced ketone 14 in a good yield. Condensation of 14 with nitromethane5) using sodium hydride in 1,2-dimethoxyethane gave adduct 15 stereospecifically in 74%yield. The 5-configuration at the C-5 position was assigned by analogy with the stereochemistry of ( -)-(2i?,3S' ,45' ,5i?)-2-acetamido-J/V-(^r/-butoxycarbonyl)-3,4,5-trihydroxy-3,4-O~isopropylidene-5-(nitromethyl)piperidine which had been determined by the X-ray crystallographic analysis shown in the preceding paper.4) A small coupling constant (/= <2 Hz) between 2-H and 3-H in the 1H NMRspectrum is indicative of the half-chair or Cs-conformer of 15. Removal of protecting groups in 15 with 4m HC1in dioxane afforded ( + )-(27?,3i?,4i?,5*S()-2-(trifluoroacetamido)-3,4,5-trihydroxy-5-(nitromethyl)piperidine (3) in 90% yield. Catalytic reduction of 15 with Raney Ni (compound 16) followed by removal of protecting groups with acid furnished ( + )-(27?,37?,4i?,57?)-5-(aminomethyl)-2-(trifluoroacetamido)-3,4,5-trihydroxypiperidine (5) in a good yield. Ninhydrin oxidation6) of the aminomethyl group of 16 to the aldehyde group and subsequent oxidation with sodium chlorite7) gave the carboxylic acid 17, which was converted upon acid treatment into ( H-)-(2^,37?,4i?,5i?)-2-(trifluoroacetamido)-3,4,5-trihydroxypiperidine-5-carboxylic acid (7) in a good yield (Scheme 1). The corresponding antipodes (4, 6 and 8) were also obtained from ll by the same sequence mentioned above (Scheme 2).
On the other hand, 9 was straightforwardly obtained from intermediate 16 ( The *H NMRspectra of compounds 15, 16, 17, 18, 19 and 20 show small coupling constants (/=~2Hz) between 2-H and 3-H, while those of3, 5, 7 and 9 show large coupling constants (/=~10Hz). These facts indicate that the fused isopropylidene and the bulky 7V-ter/-butoxycarbonyl groups of compounds having branched substituents at the C-5 position are responsible for a conformational flip from Cf-type to Cg-type or half-chair type. Similar results were observed in the previous syntheses.3'4) Biological Activities As shown in Table 1 , all analogues tested showed inhibitory activity against a-glucosidase from yeast, and some of them also inhibited /?-amylase from sweet potato. Remarkably, 7 affected strongly j#-glucuronidase from bovine liver. No analogues showed inhibitory activity against other glycosidases (a-mannosidase from soybean, a-amylase from porcine pancreas) as well as sialidases isolated from microorganisms {Streptococcus sp. , Arthrobacter ureafaciens and Clostridium perfringens) and A/Aichi/2/68 (H3N2) strain of influenza virus. Further evaluation of the biological activities of these analogues are under investigation.
Experimental
General Methods Melting points were determined with a Yanagimotoapparatus and are uncorrected. IR spectra were determined on a Hitachi Model 260-10 spectrophotometer.
Optical rotations were measured with a Perkin-Elmer Model 241 polarimeter. XH NMRspectra were recorded with Jeol GX-400 and JNM-EX270 spectrometers. Chemical shifts are expressed in S values (ppm) with tetramethylsilane as an internal standard. Mass spectra were taken by a Hitachi M-80Hfor secondary ionization and a Jeol SX102 in the FABmode.
To a solution of 10 (2.6g) in MeOH(130ml) was added anhydrous hydrazine (5ml), and the mixture was stirred at 30°C overnight. Filtration of the resulting precipitate and evaporation of the filtrate gave a viscous solid. The residue was taken up in ether, and the ethereal solution was evaporated to give an oil (2.1 g). The oil was dissolved in DMF(7.1 ml). To the solution were added diisopropylethylamine (7.1 ml) and ethyl trifluoroacetate (3.54ml), and then the mixture was stirred at room temperature overnight. (25' ,3i?,4tS,55
To a solution of 12 (2.2g) in THF (110ml) was added tetrabutylammonium fluoride (1 m solution in THF, 55 ml), and the mixture was allowed to stand at room temperature overnight. Evaporation of the solvent gave an oil which was dissolved in CHC13. The solution was washed with water, dried over MgS04, and filtered. Evaporation of the filtrate gave an oil which was subjected to column chromatography on silica gel. Elution with a mixture oftoluene-acetone (3 : 1) gave 13 as a cololress oil (1.69g, 100%): [a]£3 +48.2°(c 0.27, MeOH); IR (KBr) cm "1 3425, 3025, 2990, 2950, 1740, 1705 (sh), 1540, 1520, 1480, 1460, 1400, 1380, 1360, 1330 (sh) A solution of RuO4 in CC14 prepared from RuO2 (1.3g) and NaIO4 (10.2g) in a mixture of H2O (190ml) and CC14 (190ml) was added to a solution of 13 (1.4g) in CH2C12 (45ml) until the appearance of a yellow color, and the mixture was stirred at room temperature for 15minutes. After being quenched with 2-propanol (4ml), the mixture was diluted with CH2C12. The solution was washed with water, dried over MgSO4, and filtered. Evaporation of the filtrate gave solid 14 (1.3g). To a solution of 14 (1.3g) in a mixture of 1,2-dimethoxyethane (13 ml) and nitromethane (6ml) was added NaH (90mg) at -20°C, and the mixture was stirred at room temperature for 1.5 hours. After being quenched with acetic acid, the mixture was diluted with CHC13.The solution was washed with NaHCO3-saturated aqueous solution and then water and dried over MgSO4and filtered. The filtrate was evaporated to give a solid. The solid was crystallized from a mixture ofEtOAc and ether to give 15 as colorless crystals (1. (2iR,3 /?,4/?,5>S)-2-(Trifluoroacetamido)-3 ,4, 5-trihydroxy-5-(nitromethyl)piperidine (3) Compound 15 (20mg) was dissolved in 4m hydrogen chloride in dioxane (0.4ml), and the mixture was allowed to stand at room temperature for 2.5 hours. Another portion of 4m hydrogen chloride in dioxane (0.4ml) was added to the mixture and then the reaction mixture was further stirred at room temperature overnight. Evaporation of the solvent gave a solid. The solid was throughly washed with ether to give a colorless amorphous solid of9 as its hydrochloride (13. 3420, 3250 (sh), 3050, 2910, 1740, 1620, 1570, 1500, 1470, 1460, 1230, 1180, 1080, 1010, 950, 920 Acid (17) To a solution of 16 (747mg) in a mixture of MeOH(37ml) and water (37ml) were added ninhydrin (965 mg) and NaHCO3(437 mg), and the mixture was stirred at room temperature overnight. Evaporation of the solvent gave a solid, which was dissolved in CHC13. The CHC13solution was washed with NaCl-saturated aqueous solution, dried over MgSO4, and filtered. Evaporation of the filtrate gave a solid which was dissolved in 2-methyl-2-propanol (8 ml). To the solution were added 2-methyl-2-butene (1.6 ml) and a solution ofa mixture ofNaClO2 (1.54g) and NaH2PO4 (2.14 g) in water (8 ml), and then the mixture was stirred at roomtemperature overnight. After separation of the mixture into organic and water layers, the water layer was extracted with CHC13. The organic layer and extract were combined and evaporated. The resulting oil was subjected to preparative thin-layer chromatography on silica gel, developing with a mixture ofCHCl3-MeOH (3 : 1), to give 17 as a colorless amorphous solid (332mg, 43%): [a]£7 +36.6°( c 1.0, MeOH); IR (KBr) cm "1 3410, 3010, 2970, 1750, 1700 (sh), 1640, (sh), 1540, 1470, 1410, 1400, 1360, 1310, 1270, 1230, 1180, 1070, 990, 930 ; *H NMR (CDC13, 400MHz) S 1.26 (6H, brs, isopropylidene), (2i?,3i?,4i?,5i?)-2-(Trifluoroacetamido)-3 ,4, 5-trihydroxypiperidine-5-carboxylic Acid (7) The procedures used for the preparation of 7 were similar to those used for the preparation of 3 from 15; the yield amorphous solid 7 hydrochloride was 96%: [a]£4 + 19.7°(c 0.66, H2O); IR (KBr) cm"1 3430, 3350, 2950, 2870 (sh), 1750, 1730, 1575, 1450, 1410, 1280, 1240, 1190, 1185 (sh), 1110, 1105, 1100 (sh), 1000, 965, 940, 930; XH NMR (D2O, 400MHz) 3 3.38 (1H, d with small couplings, 7= 14Hz, 6-Heq), 3.80 (1H, d, 7=14Hz, 6-Hax) Evaporation of the solvent gave an oil, which was dissolved in CH2C12. The solution was washed with water, dried over MgSO4, and filtered. Evaporation of the filtrate gave an oil, which was subjected to column chromatography on silica gel. Elution with a mixture of toluene-acetone (10: 1) gave 18 as a colorless oil (94mg, 91%): [a]js4 +37°(c 1.0, MeOH); IR (CHC13) cm "1 3490, 3380, 3050, 3020, 2970, 1745, 1710, 1540 (sh), 1525, 1410, 1390, 1320, 1280 (sh), 1270, 1180, 1070, 990, 930 To a solution of 18 (94mg) in MeOH(3ml) was added a 7% aqueous solution of K2CO3 (5.4ml), and the mixture was stirred at room temperature overnight. Evaporation of the solvent gave an oil which was dissolved in CH2C12. The solution was washed with water, dried over MgSO4, and filtered. The filtrate was evaporated to give 19 as an oil (67mg). The oil was dissolved in DMF(1.2ml), and to the solution were successively added glycolic acid (44 mg), 1-hydroxybenzotriazole hydrate (66 mg) and DCC (104mg). Then the mixture was stirred at room temperature overnight. After filtration of the resulting precipitate, evaporation of the filtrate gave an oily residue. The residue was subjected to preparative thin-layer chromatography on silica gel, developing with a mixture of CHCl3 -MeOH(6 : 1), to give 20 as a colorless oil (59mg, 68%): |>]£4 +28°(c 0.4, MeOH); IR (CHC13) cm '1 3460, 3370, 2990, 2950, 1670, 1515, 1460, 1395, 1390, 1370, 1300, 1270, 1260, 1165, 1095, 1070, 960 (2i?,3i?,4jR, 5i?)-5-(Aminomethyl)-3 ,4, 5-trihydroxy-2-(hydroxyacetamido)piperidine (9) The procedures used for the preparation of 9 were similar to those used for the preparation of 3 from 15; the yield of amorphous solid 9 hydrochloride was 84.6%: [a]£8 +21.4°(c 0.51, H2O); IR (KBr) cm"1 3400, 3050 (sh), 2910 (sh), 1680 , 1630 , 1540 , 1465 , 1230 , 1180 , 1130 , 1080 lK NMR (D2O, 400MHz) 3 3.26, 3.33 (2H, ABq, /=14Hz, 5-CH2), 3.27 (1H, dd, 7=13.2 and 1.6Hz, 6-Heq) 
